Dr. Andrew Armstrong, MD, ScM
Claim this profileDuke University Medical Center
Studies Prostate Cancer
Studies Uterine Tumors
8 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Andrew Armstrong, MD, ScM is currently running
BMS-986460
for Prostate Cancer
This trial is testing a new drug called BMS-986460 to see if it is safe and effective for men with advanced prostate cancer that doesn't respond to hormone treatments. The goal is to find out if the drug can help control the cancer's growth and spread.
Recruiting1 award Phase 14 criteria
SAR-BBN Radiotracers
for Prostate Cancer
The aim for this study is to determine the safety and efficacy of 67Cu-SAR-BBN in participants with Gastrin Releasing Peptide Receptor (GRPR)-expressing metastatic castrate resistant prostate cancer in patients who are ineligible for therapy with 177Lu-PSMA-617.
Recruiting1 award Phase 1 & 2
More about Andrew Armstrong, MD, ScM
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Andrew Armstrong, MD, ScM has experience with
- SM08502
- Cabazitaxel
- Carboplatin
- Ipilimumab
- Nivolumab
- BMS-986460
Breakdown of trials Andrew Armstrong, MD, ScM has run
Prostate Cancer
Neuroendocrine Carcinoma
Aggression
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Armstrong, MD, ScM specialize in?
Andrew Armstrong, MD, ScM focuses on Prostate Cancer and Uterine Tumors. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andrew Armstrong, MD, ScM currently recruiting for clinical trials?
Yes, Andrew Armstrong, MD, ScM is currently recruiting for 4 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Andrew Armstrong, MD, ScM has studied deeply?
Yes, Andrew Armstrong, MD, ScM has studied treatments such as SM08502, Cabazitaxel, Carboplatin.
What is the best way to schedule an appointment with Andrew Armstrong, MD, ScM?
Apply for one of the trials that Andrew Armstrong, MD, ScM is conducting.
What is the office address of Andrew Armstrong, MD, ScM?
The office of Andrew Armstrong, MD, ScM is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.